Louied91
7 months ago
St. Joseph, Inc. Unveils Groundbreaking "VitalLink" Medical Practice Onboarding CRM (Client Relationship Management) tool.
News Link: https://www.otcmarkets.com/otcapi/company/dns/news/document/70131/content
Salt Lake City, UT, October, 16th 2023 – St. Joseph Inc. (OTC QB: STJO), a leading name in innovative healthcare solutions, proudly unveils a pioneering milestone in its journey: the launch of VitalLink, a custom-crafted proprietary Medical Practice Onboarding CRM meticulously designed and developed by a specialized team. VitalLink represents a strategic shift that will revolutionize our ability to expand and scale rapidly while ensuring a consistently exceptional experience for every provider, including doctors and customers.
In a significant departure from conventional strategies, St. Joseph, Inc. has strategically prioritized refining onboarding processes over customer acquisition. This shift, reflective of our commitment to quality and efficiency, positions us at the forefront of the healthcare industry’s evolution. By ensuring a seamless and consistent experience for every provider, including esteemed doctors and our valued customers, VitalLink stands as a testament to our dedication to delivering exceptional healthcare services.
Strategic Vision: Rapid Expansion, Exceptional Experience
"The launch of VitalLink marks a pivotal moment in our company's history," said Patrick Lewis, CEO at St. Joseph, Inc. "This cutting-edge onboarding CRM is the result of extensive research, development, and collaboration. We firmly believe it not only addresses historical industry deficiencies in onboarding doctors and enrolling patients but also has the potential to revolutionize how medical practices seamlessly integrate into our network. It underscores our commitment to putting our providers and patients at the forefront of our growth strategy."
Key Highlights of the VitalLink Onboarding CRM:
1. Seamless Integration: VitalLink streamlines the onboarding process for medical practices, allowing for quick and efficient integration into our network. This, in turn, accelerates our expansion capabilities.
2. Enhanced Provider Experience: The CRM prioritizes the needs of our providers, ensuring a smooth transition and support throughout their journey with St. Joseph, Inc.
3. Scalability: VitalLink's scalability ensures that we can rapidly adapt to the evolving healthcare landscape, making us more agile in meeting the demands of our patients and communities.
Financial Highlights:
St. Joseph, Inc. made the strategic acquisition of VitalLink, highlighting our commitment to prudent financial management while investing in innovative solutions. The infusion of VitalLink into our operations is expected to drive significant time and cost efficiencies, translating into enhanced value for our shareholders.
St. Joseph, Inc. is committed to delivering outstanding value to all stakeholders:
Shareholders: The acquisition of VitalLink underscores our commitment to growth and innovation, enhancing the long-term value proposition for our shareholders.
Customers: VitalLink's seamless onboarding process will result in a more consistent and exceptional healthcare experience for our medical clinics and doctors.
Employees: Our dedicated team will benefit from improved workflows and processes, empowering them to focus on what truly matters: delivering an exceptional and consistent experience to our customers
Industry: St. Joseph, Inc.’s commitment to refining industry standards sets a benchmark for excellence, inspiring others to prioritize innovation and efficiency.
St. Joseph, Inc.'s commitment to excellence and innovation will continue to drive our success as we embark on this transformative journey with VitalLink. We invite all our stakeholders to join us as we revolutionize healthcare onboarding and shape the future of our industry. With VitalLink as our new cornerstone, we are poised to revolutionize healthcare onboarding, paving the way for a future where exceptional patient experiences are the standard.
Welcome2Pinkyland
2 years ago
Revaluation of estimated pps
O/s looks like it will be about 100m
86,544,659 newly-issued shares of STJO, while the existing STJO shareholders shall retain
the currently issued 13,455,341 shares
$30m Revenues x’s a factor of 5 = $150 Market cap
$150m market cap divided by 100m = $1.5m
However if this company is fast growing the factor used for valuation could be 10x’s or more, so $3 or more pps.
@ 2’s revenue pps valuation would be $.60 - better than a stick in the eye.
Time tells all. $STJO $$
Potse
2 years ago
MedHab, Cypress Technologies...extremely interesting RM......
RPM has recently moved all manufacturing from Asia, where all prototyping was completed, to Leander, TX. This move was due to the ongoing supply and shipping problems facing most importing. It was also a requirement by the VA, which requires all suppliers to manufacture all supplied produced in the United States. RPM has already begun negotiations to purchase the production facility in Leander TX. This will ensure production is in place to produce devices as fast as our sales staff can sell them. It also allows local research and development to build new devices as the market needs them. RPM looks forward to adding more production companies to its operation to enhance its value to a public market in US manufacturing.
I picked up a few more shares of the STJO shell this morning under ten cents. Hard to ignore this shell/RM at that kind of legacy share valuation. The immediate post-RM share structure appears to be excellent, and it looks like there will be some interesting potential catalysts approaching.
The above paragraph from the STJO press release probably will not get as much attention as other parts of the release, but I find it quite intriguing. Cypress Technologies is the company that manufactures all of MedHab's medical devices. It will be very interesting to see if the plan is to buy part of the Cypress production facility, or if the plan is to acquire the entire company of Cypress.
https://www.linkedin.com/company/cypress-technologies/posts/?feedView=all
This January 2022 article about MedHab is an interesting read......
https://companyweek.com/article/medhab
StockRoomBully
2 years ago
Folks only 13,455,341 shares
As a condition of this agreement, STJO will receive all the assets of RPM for a total of
86,544,659 newly-issued shares of STJO, while the existing STJO shareholders shall retain
the currently issued 13,455,341 shares.
makinezmoney
2 years ago
$STJO: OHhhhhhhhh yaaaaaa.... BIG MERGER !!!!!!!!!!!!
https://www.otcmarkets.com/otcapi/company/dns/news/document/59385/content
We're going to $4/sh
GO $STJO
**************************************************************
Gerry McIlhargey, President St. Joseph, Inc. (STJO) and Patrick Lewis of RPM Assets, LLC
(RPM), are pleased to jointly announce that the two companies have completed due diligence,
and have come to an agreement to merge RPM, a specialty mainstream and alternative health
and care providing company into STJO (OTC Markets trading symbol STJO) a publicly-traded
company listed on OTC Markets.
As a condition of this agreement, STJO will receive all the assets of RPM for a total of
86,544,659 newly-issued shares of STJO, while the existing STJO shareholders shall retain
the currently issued 13,455,341 shares.
The existing Board of Directors of STJO will tender their resignations, while the management
of RPM will assume the Board of Directors’ positions in STJO. An introductory update of the
new Board members will follow.
RPM would also like to report that MedHab, one of its medical device companies that
specializes in wearable technology and holds 13 issued patents, 2 pending, and 2 more in
application phase, has successfully integrated 6 devices to meet FDA requirements as Class I
and Class II devices. They also meet FCC certifications and are HIPAA secured. MedHab
devices also meet Medicare legislation regarding Remote Patient Monitoring and Remote
Therapeutic Monitoring. This allows them to build their business from different providers such
as family practice, internal medicine, and cardiology. Additionally, MedHab is one of the few
companies in the US that has technology for both orthopedics and physical therapy. RPM is
very excited to offer such an exclusive, highly sought-after technology for the public market,
to increase shareholder value.
RPM has recently moved all manufacturing from Asia, where all prototyping was completed,
to Leander, TX. This move was due to the ongoing supply and shipping problems facing most
importing. It was also a requirement by the VA, which requires all suppliers to manufacture
all supplied produced in the United States. RPM has already begun negotiations to purchase
the production facility in Leander TX. This will ensure production is in place to produce devices
as fast as our sales staff can sell them. It also allows local research and development to build
new devices as the market needs them. RPM looks forward to adding more production
companies to its operation to enhance its value to a public market in US manufacturing.
MedHab continues to work hand-in-hand with the American Diabetes Association (ADA) to
develop commercials, participate in Q&A sessions with their devices, and help the ADA move
as many devices out to their patients as possible. MedHab is contracting with two national
physical therapy providers who collectively have over 700 clinics and 2,000 physical therapists
on staff, and expect these contracts to be signed within the next 45 to 60 days, as both have
agreed to pilots in Texas and Colorado. This equates to 50 patients for each of the 2000
physicians at a gross profit of $25.00 each month per patient. RPM is very excited about this
growth that will enhance both the market value for its customers as well as its shareholders’
value by continually adding these types of customers to its expanding portfolio.
Furthermore, RPM has taken large strides in its nutritional and alternative medicine programs
by negotiating contracts with large formulation companies to provide a much larger US-based
production opportunity as the need for sellable products increases with the number of sales
staff personnel currently moving across the country selling the RPM products. Some of these
products include meal replacements for Elderly Care, Arthritis Ointments, Memory Enhancers,
and Sleep Aids. This is also followed by a complete line of usable and PPE products to help
secure patient safety, comfortable living, and mobility success. RPM looks forward to utilizing
the public markets to access additional capital to grow its product lines, inventory, and sales
opportunities.
StockRoomBully
2 years ago
Newss
Gerry McIlhargey, President St. Joseph, Inc. (STJO) and Patrick Lewis of RPM Assets, LLC
(RPM), are pleased to jointly announce that the two companies have completed due diligence,
and have come to an agreement to merge RPM, a specialty mainstream and alternative health
and care providing company into STJO (OTC Markets trading symbol STJO) a publicly-traded
company listed on OTC Markets.
As a condition of this agreement, STJO will receive all the assets of RPM for a total of
86,544,659 newly-issued shares of STJO, while the existing STJO shareholders shall retain
the currently issued 13,455,341 shares.
The existing Board of Directors of STJO will tender their resignations, while the management
of RPM will assume the Board of Directors’ positions in STJO. An introductory update of the
new Board members will follow.
RPM would also like to report that
StockRoomBully
2 years ago
Gerry McIlhargey, President St. Joseph, Inc. (STJO) and Patrick Lewis of RPM Assets, LLC
(RPM), are pleased to jointly announce that the two companies have completed due diligence,
and have come to an agreement to merge RPM, a specialty mainstream and alternative health
and care providing company into STJO (OTC Markets trading symbol STJO) a publicly-traded
company listed on OTC Markets.
As a condition of this agreement, STJO will receive all the assets of RPM for a total of
86,544,659 newly-issued shares of STJO, while the existing STJO shareholders shall retain
the currently issued 13,455,341 shares.
The existing Board of Directors of STJO will tender their resignations, while the management
of RPM will assume the Board of Directors’ positions in STJO. An introductory update of the
new Board members will follow.
RPM would also like to report that
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Golden Cross
2 years ago
Jack_Bauer_Investing
2 years ago
Stockman1010101
2 years ago
Hot Features
Premium
